Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT
Clinical trial NCT06075927 · UNKNOWN
Trial details
- NCT number
- NCT06075927
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2025-07-30
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.